Alector (ALEC) Enterprise Value (2018 - 2026)
Alector's (ALEC) quarterly Enterprise Value came in at -$206.5 million in Q1 2026, up 41.75% year-on-year from -$145.7 million in Q1 2025, and up 19.34% on a QoQ basis from -$256.0 million in Q4 2025.
Alector (ALEC) Enterprise Value (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Enterprise Value data on file, last reported at -$206.5 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 41.75% year-over-year to -$206.5 million in Q1 2026; TTM through Mar 2026 was -$206.5 million, a 41.75% increase from a year earlier, with the FY2025 full-year figure at -$256.0 million, up 38.07% from the prior year.
- Enterprise Value for Q1 2026 stood at -$206.5 million, up from -$256.0 million in the prior quarter.
- Over the last five years, Enterprise Value for ALEC reached as high as -$206.5 million in Q1 2026 and fell as low as -$868.6 million in Q1 2022.
- Historically, Enterprise Value has averaged -$525.7 million across 5 years, with a median of -$548.9 million in 2023.
- Across the five-year window, Enterprise Value plunged 153.11% in 2022 and soared 41.75% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$712.9 million in 2022, then rose by 23.0% to -$548.9 million in 2023, then rose by 24.68% to -$413.4 million in 2024, then jumped by 38.07% to -$256.0 million in 2025, then climbed by 19.34% to -$206.5 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$206.5 million in Q1 2026, -$256.0 million in Q4 2025, and -$291.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | -206.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.52 Mn |
| Dec 31, 2025 | -256.02 Mn |
| Sep 30, 2025 | -291.11 Mn |
| Jun 30, 2025 | -307.28 Mn |
| Mar 31, 2025 | -354.55 Mn |
| Dec 31, 2024 | -413.40 Mn |
| Sep 30, 2024 | -457.20 Mn |
| Jun 30, 2024 | -503.33 Mn |
| Mar 31, 2024 | -562.08 Mn |
| Dec 31, 2023 | -548.86 Mn |
| Sep 30, 2023 | -588.86 Mn |
| Jun 30, 2023 | -630.05 Mn |
| Mar 31, 2023 | -669.33 Mn |
| Dec 31, 2022 | -712.85 Mn |
| Sep 30, 2022 | -758.31 Mn |
| Jun 30, 2022 | -808.86 Mn |
| Mar 31, 2022 | -868.57 Mn |
| Dec 31, 2021 | -735.25 Mn |
| Sep 30, 2021 | -777.85 Mn |
| Jun 30, 2021 | -319.57 Mn |